Cite

    H Liu et al.. “OP0301 Type i ifn gene signature test–high and –low patients with moderate to severe sle disease activity have distinct gene expression signatures of immunologic pathways and cell types.” Annals of the rheumatic diseases, vol. 76, n.d., pp. 180–181. http://access.bl.uk/ark:/81055/vdc_100135136369.0x00005f